Dyne Therapeutics, Inc. (DYN)
17.92
-0.14
(-0.78%)
USD |
NASDAQ |
Mar 13, 16:00
17.91
-0.01
(-0.06%)
After-Hours: 20:00
Dyne Therapeutics Total Assets (Quarterly) : 1.187B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Amicus Therapeutics, Inc. | 949.87M |
| Insmed, Inc. | 2.265B |
| MannKind Corp. | 792.18M |
| Sarepta Therapeutics, Inc. | 3.350B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 214.83M |
| Shareholders Equity (Quarterly) | 972.13M |
| Debt to Equity Ratio | 0.1741 |
| Current Ratio | 22.25 |
| Net Debt Paydown Yield | -0.89% |